|
🐜
|
Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease.
17 auth.
B. Brown,
X. Zhao,
A. Chait,
L. Fisher,
M. Cheung,
Josh S. Morse,
A. Dowdy,
E. Marino,
E. Bolson,
P. Alaupovic,
...
Jiri J. Frohlich,
Leny Serafini,
Ellen Huss-Frechette,
Shari Wang,
D. Deangelis,
A. Dodek,
J. Albers
|
10 |
2001 |
10
🐜
|
|
🐜
|
Coronary Angiographic Changes with Lovastatin Therapy: The Monitored Atherosclerosis Regression Study (MARS)
12 auth.
D. Blankenhorn,
S. Azen,
D. Kramsch,
W. Mack,
L. Cashin-Hemphill,
H. Hodis,
...
L. Deboer,
P. Mahrer,
Mary Masteller,
L. Vailas,
P. Alaupovic,
L. Hirsch
|
9 |
1993 |
9
🐜
|
|
🐜
|
VLDL, Apolipoproteins B, CIII, and E, and Risk of Recurrent Coronary Events in the Cholesterol and Recurrent Events (CARE) Trial
8 auth.
F. Sacks,
P. Alaupovic,
L. Moye,
T. Cole,
B. Sussex,
M. Stampfer,
...
M. Pfeffer,
E. Braunwald
|
8 |
2000 |
8
🐜
|
|
🐢
|
Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III.
C. S. Wang,
W. Mcconathy,
H. Kloer,
P. Alaupovic
|
8 |
1985 |
8
🐢
|
|
🐢
|
Beneficial Effects of Colestipol‐Niacin Therapy on the Common Carotid Artery. Two‐ and Four‐Year Reduction of Intima‐Media Thickness Measured by Ultrasound
8 auth.
David H. Blankenhornt,
R. Selzer,
D. Crawfordt,
J. Barth,
Chao-ran Liu Blankenhornt,
Ci-hua Liu Blankenhornt,
...
W. Mack,
P. Alaupovic
|
8 |
1993 |
8
🐢
|
|
🐢
|
Lipoprotein metabolism and renal failure.
P. Attman,
O. Samuelsson,
P. Alaupovic
|
8 |
1993 |
8
🐢
|
|
🐬
|
Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study)
L. Lindholm,
M. Persson,
P. Alaupovic,
B. Carlberg,
A. Svensson,
O. Samuelsson
|
8 |
2003 |
8
🐬
|
|
🐬
|
A lipoprotein characterizing obstructive jaundice. I. Method for quantitative separation and identification of lipoproteins in jaundiced subjects.
D. Seidel,
P. Alaupovic,
R. Furman
|
8 |
1969 |
8
🐬
|
|
🐜
|
Reduction in Carotid Arterial Wall Thickness Using Lovastatin and Dietary Therapy
9 auth.
H. Hodis,
W. Mack,
L. Labree,
R. Selzer,
Chao-ran Liu,
Ci-hua Liu,
...
P. Alaupovic,
H. Kwong-Fu,
S. Azen
|
8 |
1996 |
8
🐜
|
|
🐜
|
Triglyceride‐ and Cholesterol‐Rich Lipoproteins Have a Differential Effect on Mild/Moderate and Severe Lesion Progression as Assessed by Quantitative Coronary Angiography in a Controlled Trial of Lovastatin
9 auth.
H. Hodis,
W. Mack,
S. Azen,
P. Alaupovic,
J. Pogoda,
L. Labree,
...
L. Hemphill,
D. Kramsch,
D. Blankenhorn
|
8 |
1994 |
8
🐜
|
|
🐜
|
Lipoprotein abnormalities associated with a familial deficiency of hepatic lipase.
9 auth.
W. Breckenridge,
J. A. Little,
J. A. Little,
P. Alaupovic,
C. S. Wang,
A. Kuksis,
...
G. Kakis,
Frank T. Lindgren,
G. Gardiner
|
8 |
1982 |
8
🐜
|
|
🐬
|
Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and nonlipid factors.
D. Blankenhorn,
P. Alaupovic,
E. Wickham,
H. Chin,
S. Azen
|
8 |
1990 |
8
🐬
|
